Cancer Cells Damage Nerve Sheaths: Immunity & Resistance
- Groundbreaking research from The University of Texas MD Anderson Cancer Center, published in Nature, reveals a surprising link between cancer's ability to damage surrounding nerves and its increasing...
- For years,scientists have understood that tumors can invade and interact with nearby tissues.
- The research team, led by Moran Amit, M.D., ph.D., Neil Gross, M.D., and Jing Wang, Ph.D., discovered that cancer cells actively break down the myelin sheath - the...
How Nerve Damage Fuels Cancer’s Resistance to Immunotherapy
Table of Contents
Published August 20, 2025
Groundbreaking research from The University of Texas MD Anderson Cancer Center, published in Nature, reveals a surprising link between cancer’s ability to damage surrounding nerves and its increasing resistance to immunotherapy. This revelation underscores the growing field of cancer neuroscience and offers potential new avenues for treatment.
For years,scientists have understood that tumors can invade and interact with nearby tissues. Though,the specific impact of this interaction on the nervous system – and subsequently,the immune response – has remained largely unexplored. This study demonstrates that cancer’s infiltration of nerve spaces, a process called perineural invasion, isn’t just a sign of aggressive disease; it’s an active mechanism that undermines the body’s defenses.
How Cancer Hijacks the Nervous System
The research team, led by Moran Amit, M.D., ph.D., Neil Gross, M.D., and Jing Wang, Ph.D., discovered that cancer cells actively break down the myelin sheath – the protective covering around nerve fibers. This damage triggers an inflammatory response as the nerves attempt to heal and regenerate. While initially intended to be restorative, this inflammation becomes chronic, creating a vicious cycle.
As the tumor grows, it repeatedly injures the nerves, continually stimulating the inflammatory response. This constant activation exhausts the immune system, creating an immunosuppressive habitat within the tumor. Essentially, the cancer is using the body’s own healing mechanisms against itself, building a shield that prevents immune cells from effectively attacking the tumor.
Reversing Resistance: A New Therapeutic Target?
The study offers a glimmer of hope: targeting the cancer-induced nerve injury pathway can potentially reverse this resistance to immunotherapy. By interrupting the chronic inflammation and restoring immune function, researchers believe they can re-sensitize tumors to treatment.
“These findings uncover novel mechanisms by which the immune system and nerves within the tumor microenvironment interact, revealing actionable targets that could transform the way we approach resistance to immunotherapy in patients with cancer,” explains Dr. amit. “This marks a notable advance in our understanding of tumor-neuro-immune dynamics.”
Importantly, the researchers found that the detrimental effects on neuronal health were directly linked to perineural invasion and cancer-induced nerve injury, rather than a general effect of cancer. This highlights the critical importance of studying the specific interactions between cancer and the nervous system.
A Collaborative Effort and Future Directions
This research was a collaborative effort involving institutions including Brigham and Women’s Hospital, the University of Michigan, Moffitt Cancer Center, and Queens University. It was supported by the James P. Allison Institute and the Cancer Neuroscience Program at MD Anderson, reflecting a growing commitment to understanding the complex interplay between cancer and the nervous system.
MD Anderson’s Cancer Neuroscience Program is actively investigating the broader implications of these findings,exploring themes such as neurobiology,brain and spine tumors,neurotoxicities,and neurobehavioral health.The goal is to develop a more comprehensive understanding of how the nervous system impacts the entire cancer journey, from diagnosis to treatment and beyond.
